Persistence of microscopic human cancers in mice: Alterations in the angiogenic balance accompanies loss of tumor dormancy

FASEB Journal

Volumn 16, Issue 11, 2002, Pages 1361-1370

  Udagawa, Taturo ^a   Fernandez, Antonio ^a,c   Achilles, Eike Gert ^a,d   Folkman, Judah ^a   D'Amato, Robert J ^a,b,e,f  

^a Children's Hospital   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Unidad de Investigacion   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e Department of Surgery   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Angiogenesis; Dormant tumors; Occult cancers

Indexed keywords

GREEN FLUORESCENT PROTEIN; RAS PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MICROSCOPIC ANATOMY; MOUSE; NONHUMAN; ONCOGENE C H RAS; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR RECURRENCE;

ANIMALS; APOPTOSIS; CELL DIVISION; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOCOMPROMISED HOST; INDICATORS AND REAGENTS; LUMINESCENT PROTEINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0036720684     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0813com     Document Type: Article

References (48)

1. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy
2. Prolonged survival in breast cancer
3. Relationship between disease-free interval and survival in patients with recurrent melanoma
4. Local recurrences following mastectomy: Support for the concept of tumor dormancy
5. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy
6. Unknown primary head and neck squamous cell carcinoma: Molecular identification of the site of origin
7. Non-random primary and secondary chromosomal abnormalities in human gastric cancers
8. Human interferon: Mass production in a newly established cell line MG- 63
9. New human tumor cell lines
10. Mechanism of activation of a human oncogene
11. Osteogenic sarcoma: An analysis of eighty cases
12. Disseminated carcinomatosis of the bone marrow occurring 11 years after subtotal gastrectomy for gastric cancer
13. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases
14. Breast cancer atypia among young and middle-aged women: A study of 110 medicolegal autopsies
15. Occult papillary carcinoma of the thyroid. A 'normal' finding in Finland. A systematic autopsy study
16. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer
17. Occult malignant astrocytoma of pons with extracranial metastasis to bone prior to craniotomy
18. Histologic and biologic patterns of microscopic pancreatic ductal adenocarcinomas detected incidentally at autopsy
19. In situ neuroblastomas: A contribution to the natural history of neural crest tumors
20. Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy
21. Early gastric cancer in young, asymptomatic carriers of germ-line E-Cadherin mutations
22. Tumor dormancy in vivo by prevention of neovascularization
23. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma
24. Dormancy of micrometastasis: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
25. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
26. The dormant in vivo phenotype of early stage primary human melanoma: Termination by overexpression of vascular endothelial growth factor
27. Induction of angiogenesis during the transition from hyperplasia to neoplasia
28. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis
29. The multistep nature of cancer
30. Regulation of FGF-3 expression in tumorigenic and non-tumorigenic clones of a human colon carcinoma cell line
31. Is xenotransplantability of human colon cancers in SCID mice affected by angiogenic factors?
32. Heterogeneity of angiogenic activity in a human liposarcoma: A proposed mechanism for 'no take' of human tumors in mice
33. Basement membrane and the SIKVAV laminin-derived peptide promote tumor growth and metastases
34. Reciprocal paracrine interactions between tumour cells and endothelial cells: The 'angiogenesis progression' hypothesis
35. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways
36. Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells
37. Essential role for oncogenic Ras in tumour maintenance
38. Growth factors and cancer
39. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms
40. Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
41. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
42. Repression of thrombospondin-1 expression, a natural inhibitor of angiogenesis, in polyoma middle T transformed NIH3T3 cells
43. Oncogenes and angiogenesis: Signaling three-dimensional tumor growth
44. An in vivo function for the transforming Myc protein: Elicitation of the angiogenic phenotype
45. Overexpression of bcl-2 in prostate carcinoma cells increases angiogenic potential independent of bcl-2's anti-apoptotic properties
46. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells
47. p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma
48. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 OR BRCA2 mutation